Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AB521 |
Trade Name | |
Synonyms | AB-521|AB 521 |
Drug Descriptions |
AB521 selectively inhibits HIF-2alpha, potentially resulting in downregulation of HIF-2alpha target genes and antitumor activity (Ann Oncol 33 (2022): S21). |
DrugClasses | HIF2A Inhibitor 6 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AB521 | AB521 | 0 | 1 |
AB521 + Nivolumab + XL092 | AB521 Nivolumab XL092 | 0 | 1 |
AB521 + XL092 | AB521 XL092 | 0 | 1 |